Skip to main content
SpringerLink
Log in

Neuronal pathology in relation to molecular biology and treatment of Alzheimer’s disease

  • Chapter
Molecular and Cell Biology of Neuropsychiatric Diseases

Part of the book series: Molecular and Cell Biology of Human Diseases Series ((Mol. Cell Biol. Hu. Dis.))

  • 59 Accesses

Abstract

Alois Alzheimer (1864–1915) combined the clinical and pathological approach to brain disease, and made the study of dementia his special sphere. In the course of these studies in 1907 he published the report ‘On a Peculiar Disease of the Cerebral Cortex’ (Uber eine eigenartige Erkrankung de Hirnrinde) (see Wilkins and Brody, 1969). This ‘peculiar disease’ was soon to be designated Alzheimer’s disease (AD) by Alois’s head of department, Kraepelin. The original report described a 56-year-old woman who had died following a five- to six-year illness characterized by disorientation, memory loss and personality changes. Post-mortem microscopic examination of cortical brain tissue revealed a high density of lesions currently described as senile plaques and neurofibrillary tangles, along with loss of pyramidal neurones.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allen S.J. (1984) Neurochemical changes in normal ageing and Alzheimer’s disease, University of London, PhD Thesis.

    Google Scholar 

  • Anderson K.J., Bridges, R.J. and Cotman, C.W. (1991) Increased density of excitatory amino acid transport sites in the hippocampal formation following an entorhinal lesion. Brain Res., 562, 285–290.

    Article  PubMed  CAS  Google Scholar 

  • Andrade, R. and Nicoll, R.A. (1987) Novel anxiolytics discriminate between postsynaptic and presynaptic mediating different physiological responses on single neurones of the rat hippocampus. Naunyn-Schmiedeberg’s Arch. Pharmacol. Exp. Pathol,. 336, 5–10.

    CAS  Google Scholar 

  • Araneda, R. and Andrade, R. (1991) 5-Hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience, 40, 399–412.

    Article  PubMed  CAS  Google Scholar 

  • Ball, M.J. (1978) Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitive study. Acta Neuropathol, 42, 73–80.

    Article  PubMed  CAS  Google Scholar 

  • Beal, M.F., Mazurek, M.H., Chattha, G.K. et al. (1986) Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer’s disease. Ann. Neurol., 20, 282–288.

    Article  PubMed  CAS  Google Scholar 

  • Beal, M.F., Clevens, R.A., Chattha, G.K. et al. (1988) Galanin-like immunoreactivity is unchanged in Alzheimer’s disease and Parkinson’s disease. J. Neurochem., 51, 1935–1941.

    Article  PubMed  CAS  Google Scholar 

  • Becker, R.E. (1991) Therapy of the cognitive deficit in Alzheimer’s disease, in Cholinergic basis for Alzheimer’s therapy, (eds R.E. Beck and E. Giacobini) Birkhauser, Boston, pp. 1–22.

    Google Scholar 

  • Birnbaumer, L. (1990) G Proteins in signal transduction. Anna. Rev. Pharmacol. Toxico., 30, 675–705.

    Article  CAS  Google Scholar 

  • Bjork, L., Cornfield, L.J., Nelson, D.L. et al. (1991) Pharmacology of the novel 5-hydroxytryptamine 1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino) tetralin: inhibition of (R)-8-hydroxy 2-(dipropylamino)tetralin-induced effects./. Pharmacol. Exp. Ther., 258, 58–65.

    CAS  Google Scholar 

  • Bowen, D.M., (1990) Treatment of Alzheimer’s disease: molecular pathology versus neurotransmitter-based therapy. Br. J. Psychiatry, 157, 327–330.

    Article  PubMed  CAS  Google Scholar 

  • Bowen, D.M., Francis, P.T., Pangalos, M.N. et al. (1992) Treatment strategies for Alzheimer’s disease. Lancet, 339, 132–133.

    Article  PubMed  CAS  Google Scholar 

  • Bowen, D.M., White, P., Spillane, J.A. et al. (1979) Accelerated ageing or selective neuronal loss as an important cause of dementia. Lancet, 1, 11–14.

    PubMed  CAS  Google Scholar 

  • Bowen, D.M., Allen, S.J., Benton, J.S. et al. (1983) Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer’s disease. J. Neurochem., 41, 266–272.

    Article  PubMed  CAS  Google Scholar 

  • Bowen, D.M., Beyreuther, K., Cross, A. J. et al. (1988) Cell injury: Molecular biology and genetic basis, in Etiology of Dementia of the Alzheimers Lype, (eds A.S. Henderson and J.H. Henderson), Wiley, Chichester, pp. 165–176.

    Google Scholar 

  • Bowen, D.M., Najlerahim, A., Procter, A.W. et al. (1989) Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Proc. Natl. Acad. Sci. USA, 86, 9504–9508.

    Article  PubMed  CAS  Google Scholar 

  • Braak, H. and Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol., 82, 239–259.

    Article  PubMed  CAS  Google Scholar 

  • Chalmers, D.T., Dewar, D., Graham, D.I. et al. (1990) Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type. Proc. Natl. Acad. Sci. USA, 87, 1325–1356.

    Article  Google Scholar 

  • Chawluk, J.B., Alavi, A., Dann, R., Zimmerman, R.A. and Reivich, M.J. (1987) Positron emission tomography in aging and dementias; effect of cerebral atrophy. J. Nucl. Med., 28, 431–437.

    PubMed  CAS  Google Scholar 

  • Christensen, I.T., Reinhardt, A., Nielsen, B. et al. (1989) Excitatory amino acid agonists and partial agonists. Drug Design and Delivery, 5, 57–71.

    Google Scholar 

  • Christie, J.E., Shering, A., Ferguson, J. and Glen, A.I.M. (1981) Physostigmine and arecoline; effects of intravenous infusions in Alzheimer’s presenile dementia. Br. J. Psychiatry, 138, 46–50.

    Article  PubMed  CAS  Google Scholar 

  • Chu, C.M., Penney, J.B. and Young, A.B. (1987) Cortical GABAB and GABAA receptors in Alzheimer’s disease: A quantative autoradiographic study. Neurology, 37, 1454–1459.

    Article  PubMed  CAS  Google Scholar 

  • Cole, J.O. and Branconnier, R. (1978) The therapeutic efficacy of psychopharmacologic agents in senile organic brain syndrome in senile dementia, in Senile Dementia; A Biochemical Approach, (ed K. Nandy), Elsevier, New York, pp. 271–286.

    Google Scholar 

  • Colino, A. and Halliwell, J.V. (1987) Differential modulation of three separate K-conductances in hippocampal CA1 neurones by serotonin. Nature, 328, 73–77.

    Article  PubMed  CAS  Google Scholar 

  • Copani, A., Koh, J.Y. and Cotman, C.W. (1991) α-Amyloid increases neuronal susceptibility to injury by glucose deprivation. NeuroReport, 2, 763–765.

    Article  PubMed  CAS  Google Scholar 

  • Cordi, A.A., Monahan, J.B., and Reisse, J. (1990) A topological model of the NMDA-glycine receptor model. J. Receptor Res., 10, 299–315.

    CAS  Google Scholar 

  • Corsellis, J.A.N. (1962) Mental illness and the ageing brain, in Maudsley Monograph No. 9, Oxford University Press, London, pp. 29–32.

    Google Scholar 

  • Cowburn, R.F., Hardy, J.A. and Roberts, P.J. (1989) Neurotransmitter deficits in Alzheimer’s disease, in Alzheimer’s Disease Towards an Understanding of the Aetiology and Pathogenesis, (ed. D.C. Davies), Libby, London, pp. 9–32.

    Google Scholar 

  • Cowburn, R.F., Neil, C.O., Ravid, R. et al. (1992) Adenylyl cylase activity in postmortem human brain: Evidence of altered G protein mediation in Alzheimer’s disease. J. Neurochem., 58, 1409–1419.

    Article  PubMed  CAS  Google Scholar 

  • Crapper-McLachlan, D.R., Dalton, A.J., Kruck, T.P.A. et al. (1991) Intramuscular desferrioxamine in patients with Alzheimer’s disease. Lancet, 337, 1304–1308.

    Article  PubMed  CAS  Google Scholar 

  • Cross, A.J., and Slater, P. (1989) High affinity serotonin binding sites in human brain: a comparison of cerebral cortex and basal ganglia. J. Neural. Transm., 76, 211–219.

    Article  PubMed  CAS  Google Scholar 

  • Cross, A.J., Skan, W.J. and Slater, P. (1986) The association of [3H]-D-aspartate finding and high-affinity glutamate uptakes in the human brain. Neurosci. Lett., 63, 121–124.

    Article  PubMed  CAS  Google Scholar 

  • Cutler, N.R., Haxby, J.V., Duara, R. et al. (1985) Clinical history, brain metabolism and neuropsychological function in Alzheimer’s disease. Ann. Neurol., 18, 298–309.

    Article  PubMed  CAS  Google Scholar 

  • Danbolt, N.C. and Storm-Mathisen, J. (1986) Sodium dependent binding of D-aspartate in membranes is largely due to uptake into membrane bound saccules. J. Neurochem., 47, 819–824.

    Article  PubMed  CAS  Google Scholar 

  • Davies, M.F., Deisz, R.A., Prince, D.A. and Peroutka, S.J. (1987) Two distinct effects of 5-hydroxytryptamine on single cortical neurones. Brain Res., 423, 347–352.

    Article  PubMed  CAS  Google Scholar 

  • Davies, P. (1991) Therapy for Alzheimer’s disease: choosing a target. Clin. Neuropharmacol., 14, S24–S33.

    Article  PubMed  Google Scholar 

  • Davies, K.L., Hollander, E., Davidson, M. et al. (1987) Induction of depression with oxotremorine in Alzheimer’s disease patients. Am. J. Psychiatry, 144, 468–471.

    Google Scholar 

  • DeFilipe, J. and Jones, E.G. (1988) Cajal on the Cerebral Cortex: An Annotated Translation of the Complete Writings, Oxford University Press, Oxford, pp. 557–621.

    Google Scholar 

  • Dehlin, O., Hedenrud, B., Janson, P. and Norgaard, J.A. (1985) A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia. Acta Psychiatr. Scand., 71, 190–196.

    Article  PubMed  CAS  Google Scholar 

  • DeKosky, S.T. and Scheff, S.W. (1990) Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann. Neurol., 27, 457–464.

    Article  PubMed  CAS  Google Scholar 

  • Dewar, D., Chalmers, D.T., Graham, D.I. and McCullough, J. (1991) Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer’s disease: an autoradiographic study of the hippocampus. Brain Res., 553, 58–64.

    Article  PubMed  CAS  Google Scholar 

  • Dresse, A. and Scuvee-Moreau, J. (1988) Electrophysiological effects of tianeptine on rat locus coeruleus, raphe dorsalis, and hippocampus activity. Clin. Neuropharmacol., 11, 551–558.

    Google Scholar 

  • Esiri, M.M., Pearson, R.C.A., Steele, J.E. et al. (1990) A qualitative study of the neurofibrillary tantles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry, 53, 161–165.

    Article  PubMed  CAS  Google Scholar 

  • Essman, W.B. (1973) Age dependent effects of 5-hydroxytryptamine upon memory consolidation and cerebral protein synthesis. Pharmacol. Biochem. Behav., 1, 7–14.

    Article  PubMed  CAS  Google Scholar 

  • Fibiger, H.C. (1991) Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci., 14, 220–223.

    Article  PubMed  CAS  Google Scholar 

  • Fibiger, H.C., Lepiane, F.G and Phillips, A.G. (1978) Disruption of memory produced by stimulation of the dorsal raphe nucleus: mediation by serotonin. Brain Res., 155, 380–386.

    Article  PubMed  CAS  Google Scholar 

  • Fletcher, A., Bill, D.J., Brammer, N.T. et al. (1991) WAY 100135: A novel and highly selective 5-HT1A receptor antagonist. Soc. Neurosci., Abs., 17, 92.

    Google Scholar 

  • Fowler, C.J., O’Neill, C., Garlind, A. and Cowburn, R.F. (1990) Alzheimer’s disease; is there a problem beyond recognition? TIPS, 11, 183–184.

    PubMed  CAS  Google Scholar 

  • Francis, P.T.and Bowen, D.M. (1989) Tacrine, a drug with therapeutic potential for dementia: post-mortem biochemical evidence. Can. J. Neurol. Sci., 16, 504–510.

    PubMed  CAS  Google Scholar 

  • Francis, P.T., Bowen, D.M., Neary, D. et al. (1984) Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients. Neurobiol Aging, 5, 183–186.

    Article  PubMed  CAS  Google Scholar 

  • Francis, P.T., Palmer, A.M., Sims, N.R. et al. (1985) Neurochemical studies of earlyonset Alzheimer’s disease. Possible influence on treatment. N. Engl. J. Med., 313, 7–11.

    Article  PubMed  CAS  Google Scholar 

  • Francis, P.T., Bowen, D.M., Lowe, S.L. et al. (1987) Somatostatin content and release measured in cerebral biopsies from demented patients. J. Neurol. Sci., 78, 1–16.

    Article  PubMed  CAS  Google Scholar 

  • Francis, P.T., Pangalos, M.N., Stephens, P.H. et al. (1993a) Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer’s disease and depression. J. Neurol Neurosurg. Psychiatry, 56, 80–84.

    Article  PubMed  CAS  Google Scholar 

  • Francis, P.T., Sims, N.R., Procter, A.W. and Bowen, D.M. (1993b) Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer’s disease: investigative and therapeutic perspectives. J. Neurochem., 60, 1589–1604.

    Article  PubMed  CAS  Google Scholar 

  • Francis, P.T., Pangalos, M.N., Pearson, R.C.A. et al. (1992) 5-HT1A but not 5-HT2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin. J. Pharmacol Exp. Ther., 261, 1273–1281.

    PubMed  CAS  Google Scholar 

  • Freeman, S.E. and Dawson, R.M. (1991) Tacrine: A pharmacological review. Prog. Neurol, 36, 257–277.

    Article  CAS  Google Scholar 

  • Geaney, D.P., Soper, N., Shepstone, B.J., Cowen, P.J. (1990) Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer’s disease. Lancet, 335, 1484–1487.

    Article  PubMed  CAS  Google Scholar 

  • Giacobini, E., Linville, D., Messamore, E., Ogane, N. (1991) Toward a third generation of cholinesterase inhibitors, in Cholinergic Basis for Alzheimer’s Therapy, (eds R.E. Becker and E. Giacobini), Birkhauser, Boston, pp. 477–900.

    Google Scholar 

  • Goodhardt, M.J. (1980) Neurotransmitter uptake and binding in ischaemia and organic dementia, University of London, PhD Thesis.

    Google Scholar 

  • Greenamyre, J.T. and Young, A.B. (1989) Excitatory amino acids in Alzheimer’s disease. Neurobio. Aging, 10, 593–602.

    Article  CAS  Google Scholar 

  • Greenamyre, J.T., Higgins, D.S. and Young, A.B. (1990) Sodium dependent Dd-aspartate binding is not a measure of presynaptic neuronal uptake sites in an autoradiographic assay. Brain Res., 511, 310–318.

    Article  PubMed  CAS  Google Scholar 

  • Gustafson, L., Edvinsson, L., Dahlgren, N. et al. (1987) Intravenous physostigmine treatment of Alzheimer’s disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG. Psychopharmacology, 93, 31–35.

    Article  PubMed  CAS  Google Scholar 

  • Gutteridge, J.M., Quinlan, G.J., Clark, G.J. and Halliwell, B. (1985) Aluminium salts accelerate peroxidation of membrane lipids by iron salts. Biochim. Biophys. Acta, 835, 441–447.

    Article  PubMed  CAS  Google Scholar 

  • Halliwell, J.V. (1986) M-Current in human neocortical neurones. Neurosci. Lett., 67, 1–6.

    Article  PubMed  CAS  Google Scholar 

  • Harbaugh, R.E. (1987) Intracerebroventricular bethanecol administration in Alzheimer’s disease; preliminary results of a double blind study. J. Neurol. Transm., 24(Suppl.), 271–277.

    CAS  Google Scholar 

  • Hardy, J.A. and Higgins, G.A. (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science, 256, 184–185.

    Article  PubMed  CAS  Google Scholar 

  • Harrison, P.J. and Pearson, R.C.A. (1990) In situ hybridisation histochemistry and the study of gene expression in the human brain. Prog. Neurobiol., 34, 271–312.

    Article  PubMed  CAS  Google Scholar 

  • Hoffman, A., Rocca, W.A., Brayne, C. et al. (1991) The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Int. J. Epidemiol., 20, 736–748.

    Article  Google Scholar 

  • Hollander, E., Davidson, M., Mohrs, R.C. et al. (1987) RS 86 in the treatment of Alzheimer’s disease: cognitive and biological effects. Biol. Psychiatry, 22, 1067–1078.

    Article  PubMed  CAS  Google Scholar 

  • Hoyer, D., Schoeffter, P., Palacios, J.M. et al. (1992) A selective, potent and silent 5-HT1A receptor antagonist. Br. J. Pharmacol, (in press).

    Google Scholar 

  • Hyman, B.T., Van Hoesen, G.W. and Damasio, A.R. (1987) Alzheimer’s disease; glutamate depletion in the hippocampal perforant pathway zone. Ann. Neurol, 22, 37–40.

    Article  PubMed  CAS  Google Scholar 

  • Iversen, L.L., Bentley, G., Dawson, G. et al. (1991) Heptylphysostigmine— novel acetylcholinesterase inhibitor: biochemical and behavioural pharmacology, in Cholinergic Basis for Alzheimer’s Therapy, (eds R.E. Beckerand E. Giacobini), Birkhansen, Boston, pp. 297–304.

    Google Scholar 

  • Jansen, K.L.R., Faull, R.L.M., Dragnunow, M. and Synek, B.L. (1990) Alzheimer’s disease; changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors— an autoradiographic study. Neuroscience, 32, 613–627.

    Article  Google Scholar 

  • Katzman, R. (1976) The prevelance and malignancy of Alzheimer’s disease. Arch. Neurol, 33, 217–218.

    Article  PubMed  CAS  Google Scholar 

  • Kesslak, J.P., Nalcioglu, O. and Cotman, C.W. (1991) Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer’s disease. Neurology, 41, 51–54.

    Article  PubMed  CAS  Google Scholar 

  • Korey, S.R., Scheinberg, L., Terry, R. and Stein, A. (1961) Studies in presenile dementia. Trans. Am. Neurol Assoc., 86, 99–102.

    PubMed  CAS  Google Scholar 

  • Lawlor, B.A., Sunderland, T., Mellow, A.M. et al. (1989) Hyperresponsivity to the serotonin agonist m-chlorphenylpiperazine in Alzheimer’s disease: a controlled study. Arch. Gen. Psychiatry, 46, 542–549.

    Article  PubMed  CAS  Google Scholar 

  • Liau, L.M., Sleight, A.J., Pitha, J. and Peroutka, S.J. (1991) Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist. Pharmacol. Biochem. Behav., 38, 555–559.

    Article  PubMed  CAS  Google Scholar 

  • Lowe, S.L., Francis, P.T., Procter, A.W. et al. (1988) Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer’s disease. Brain, 111, 785–799.

    Article  PubMed  Google Scholar 

  • Lowe, S.L., Bowen, D.M., Francis, P.T. and Neary, D. (1990) Ante-mortem cerebral amino acid concentrations indicate selective degeneration of glutamateenriched neurons in Alzheimer’s disease. Neuroscience, 38, 571–577.

    Article  PubMed  CAS  Google Scholar 

  • McCormick, D.A. and Williamson, A. (1989) Convergence and divergence of neurotransmitter action in human cerebral cortex. Proc. Natl. Acad. Sci, USA, 86, 8098–8102.

    Article  PubMed  CAS  Google Scholar 

  • McEntee, W.J. and Crook, T.H. (1991) Serotonin, memory, and the aging brain. Psychopharmacology, 103, 143–149.

    Article  PubMed  CAS  Google Scholar 

  • McLaughlin, M., Ross, B.M., Milligan, G. et al. (1991) Robustness of G proteins in Alzheimer’s disease: an immunoblot study. J. Neurochem., 57, 9–14.

    Article  PubMed  CAS  Google Scholar 

  • McPherson, G.A. (1985) Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC. J. Pharmacol. Meths., 14, 213–228.

    Article  CAS  Google Scholar 

  • Manallack, D.T., Wong, M.G., O’Shea, R.D. and Beart, P.M. (1990) Topography of the glycine site of the NMDA receptor. Mol. Neuropharmacol., 1, 7–15.

    CAS  Google Scholar 

  • Mantz, J., Godbout, R., Tassin, J.P. et al. (1990) Inhibition of spontaneous and evoked unit activity in the rat medial prefrontal cortex by mesencephalic raphe nuclei. Brain Res., 524, 22–30.

    Article  PubMed  CAS  Google Scholar 

  • Martin, J.B., Beal, M.F., Mazurek, M. et al. (1988) Some observations on the significance of neurotransmitter changes in Alzheimer’s disease, in Aging and the brain, (ed. R.D. Terry), Raven Press, New York, pp. 129–148.

    Google Scholar 

  • Mattson, M.P., Cheng, B., Davis, D. et al. (1992) α-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci., 12, 376–389.

    PubMed  CAS  Google Scholar 

  • Maura, G., Roccatagliatta, E., Ulivi, M. and Raiteri, M. (1988) Serotonin-glutamate interaction in rat cerebellum: Involvement of 5-HT1 and 5-HT2 receptors. Eur. J. Pharmacol., 145, 31–38.

    Article  PubMed  CAS  Google Scholar 

  • Maura, G., Barzizza, A., Floghera, S. and Raiteri, M. (1991) Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype. Naunyn-Schmiederbergs Arch Pharmacol., 343, 229–236.

    CAS  Google Scholar 

  • Millan, M.J., Rivet, J.M., Canton, H. et al. (1991) Benzodioxepiperazine derivatives as novel 5-HT1A antagonists: a pharmacological characterization. Soc. Neurosa. Abs., 17, 92.

    Google Scholar 

  • Miller, J.D., De Leon, M.J., Ferris, S.H. et al. (1987) Abnormal temporal lobe response in Alzheimer’s disease during congnitive processing as measured by 11C-2-deoxy-D-glucose and PET. J. Cerebr. Blood Flow Metab., 7, 248–251.

    Article  CAS  Google Scholar 

  • Mohr, E., Bruno, G., Foster, N. et al. (1986) GABA-agonist therapy for Alzheimer’s disease. Clin. Neuropharmacol., 9, 257–263.

    Article  PubMed  CAS  Google Scholar 

  • Mohs, R.C. and Davis, K.L. (1987) The experimental pharmacolocy of Alzheimer’s disease and related dementias, in Psychopharmacology: The Third Generation of Progress, (ed. Meitzer), Raven Press, New York, pp. 921–980.

    Google Scholar 

  • Mouradian, M.M., Mohr, E., Williams, A.J. and Chase, T.N. (1988) No response to high-dose muscarinic agonist therapy in Alzheimer’s disease. Neurology, 38, 606–608.

    Article  PubMed  CAS  Google Scholar 

  • Mouradian, M.M., Blin, J., Giuffra, M. et al. (1991) Somatostatin replacement therapy of Alzheimer’s dementia. Ann. Neurol., 30, 610–613.

    Article  PubMed  CAS  Google Scholar 

  • Murphy, D.L. (1990) Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes. Neuropsychopharmacology, 3, 457–470.

    PubMed  CAS  Google Scholar 

  • Near/, D., Snowden, J.S., Mann, D.M. et al. (1986) Alzheimer’s disease: a correlative study. J. Neurol. Neurosurg. Psychiatry, 49, 229–237.

    Article  Google Scholar 

  • Neary, D., Snowden, J.S., Sheilds, R.A. et al., (1987) Single photon emission tomography using [99m]Tc-HM-PAO in the investigation of dementia. J. Neurol. Neurosurg. Psychiatry, 50, 1101–1109.

    Article  PubMed  CAS  Google Scholar 

  • Newhouse, P.A., Sunderland, T., Tariot, P.N. et al. (1988) IV nicotine in Alzheimer’s disease, a pilot study. Psychopharmacology, 95, 2–11.

    Article  Google Scholar 

  • Nyth, A.L. and Gottfries, C.G. (1990) The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. Brit. J. Psychiatry, 157, 894–901.

    Article  CAS  Google Scholar 

  • O’Neill, C., Cowburn, R.F., Weihager, B. et al. (1991) Preservation of 5-hydroxytryptamine1A receptor-G protein interactions in the cerebral cortex of patients with Alzheimer’s disease. Neurosci. Lett., 133, 15–19.

    Article  PubMed  Google Scholar 

  • Ogren, S. (1982) Central serotonin neurones and learning in the rat, in Biology of serotonergic transmission, (ed. N.N. Osborne), Wiley, London, pp. 751–763.

    Google Scholar 

  • Ogren, S. and Johansson, C. (1985) Separation of the associative and nonassociative effects of brain serotonin released by p-chloroamphetamine: dissociable serotonergic involvement in avoidance learning, pain and motor function. Psychopharmacology, 86, 12–26.

    Article  PubMed  CAS  Google Scholar 

  • Palmer, A.M. (1987) Central monoamine neurones in Alzheimer’s disease, University of London, PhD Thesis, pp. 56-69.

    Google Scholar 

  • Palmer, A.M., Sims, N.R., Bowen, D.M. et al. (1984) Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer’s dementia. J. Neurol. Neurosurg. Psychiatry, 47, 481–484.

    Article  PubMed  CAS  Google Scholar 

  • Palmer, A.M., Francis, P.T., Benton, J.S. et al. (1987a) Presynaptic serotonergic dysfunction in patients with Alzheimer’s disease. J. Neurochem., 48, 8–15.

    Article  PubMed  CAS  Google Scholar 

  • Palmer, A.M., Francis, P.T., Benton, J.S. et al. (1987b) Catecholaminergic neurones assessed ante-mortem in Alzheimer’s disease. Brain Res., 414, 365–375.

    Article  PubMed  CAS  Google Scholar 

  • Palmer, A.M., Wilcock, G.K., Esiri, M.M. et al. (1987c) Monoaminergic innervation of the frontal and temporal lobes in Alzheimer’s disease. Brain Res., 401, 231–238.

    Article  PubMed  CAS  Google Scholar 

  • Palmer, A.M., Stratmann, G.C., Procter, A.W. and Bowen, D.M. (1988) Possible neurotransmitter basis of bahavioural changes in Alzheimer’s disease. Ann. Neurol., 23, 616–620.

    Article  PubMed  CAS  Google Scholar 

  • Pangalos, M.N. (1992) Biochemical approaches to investigate neocortical pyramidal neurones. University of London, PhD Thesis.

    Google Scholar 

  • Pangalos, M.N., Francis, P.T., Middlemiss, D.N. et al. (1991) Selective destruction of a sub-population of cortical neurones by suicide transport of volkensin, a lectin from Adenia volkensii, J. Neurosci. Meth., 40, 17–29.

    Article  CAS  Google Scholar 

  • Pazos, A., Probst, A. and Palacios, J.M. (1987) Serotonin receptors in the human brain-III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience, 21, 97–122.

    Article  PubMed  CAS  Google Scholar 

  • Peinado, J.M. and Mora, F. (1986) Glutamic acid as putative transmitter of the interhemispheric corticocortical connections in the rat. J. Neurochem., 47, 1598–1603.

    Article  PubMed  CAS  Google Scholar 

  • Penney, J.B., Maragos, W.F., Greenmyre, J.T. et al. (1990) Exictatory amino acid binding sites in the hippocampal region of Alzheimer’s disease and other dementias. J. Neurol. Neurosurg. Psychiatry, 53, 314–320.

    Article  PubMed  CAS  Google Scholar 

  • Perry, E.K. and Perry, R.H. (1985) A review of neuropathological and neurochemical correlates of Alzheimer’s disease. Danish Med. Bull., 32(Suppl. 1), 27–34.

    PubMed  CAS  Google Scholar 

  • Perry, E.K., Perry, R.H. and Tomlinson, B.E. (1982) The influence of agonal status on some neurochemical activities of postmortem human brain tissue. Neurosci. Lett., 29, 303–307.

    Article  PubMed  CAS  Google Scholar 

  • Procter, A.W., Lowe, S.L., Palmer, A.M. et al. (1988a) Topographical distribution of neurochemical changes in Alzheimer’s disease. J. Neurol. Sci., 84, 125–140.

    Article  PubMed  CAS  Google Scholar 

  • Procter, A.W., Palmer, A.M., Francis, P.T. et al. (1988b) Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer’s disease. J. Neurochem., 50, 790–802.

    Article  PubMed  CAS  Google Scholar 

  • Procter, A.W., Stirling, J.M., Stratmann, G.C. et al. (1989a) Loss of glycinedependent radioligand binding to the N-methyl-D-aspartate-phencyclidine receptor complex in patients with Alzheimer’s disease. Neurosci. Lett., 101, 62–66.

    Article  PubMed  CAS  Google Scholar 

  • Procter, A.W., Wong, E.H., Stratmann, G.C. et al. (1989b) Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer’s disease. J. Neurochem., 53, 698–704.

    Article  PubMed  CAS  Google Scholar 

  • Procter, A.W., Stratmann, G.C., Francis, P.T. et al. (1991) Characterization of the glycine modulatory site of the N-methyl-D-aspartate receptor ionophore complex in human brain. J. Neurochem., 56, 299–310.

    Article  PubMed  CAS  Google Scholar 

  • Procter, A.W., Francis, P.T., Stratmann, G.C. and Bowen, D.M. (1992) Serotonergic pathology is not widespread in Alzheimer patients without prominent behaviour symptoms. Neurochem. Res., 17, 917–922.

    Article  PubMed  CAS  Google Scholar 

  • Raiteri, M., Maura, G. and Barzizza, A. (1991) Activation of presynaptic 5-HT1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate induced cyclic GMP production on rat cerebellar slices. J. Pharmacol. Exp. Therapeut., 257, 1184–1185.

    CAS  Google Scholar 

  • Raiteri, M., Maura, G., Bonanno, G. and Pittaluga, A. (1986) Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. J. Pharmacol. Exp. Ther., 237, 644–648.

    PubMed  CAS  Google Scholar 

  • Rakonczay, Z. (1988) Cholinesterase and its molecular forms in pathological states. Prog. Neurol., 31, 311–330.

    Article  CAS  Google Scholar 

  • Raskind, M.A., Peskind, E.R., Halter, J.B. and Himerson, D.C. (1984) Norepinephrine and MHPG levels in CSF and plasma in Alzheimer’s disease. Arch. Gen. Psychiatry, 41, 343–346.

    Article  PubMed  CAS  Google Scholar 

  • Reinikainen, K.J., Paljarvi, L., Huuskonen, M. et al. (1988) A postmortem study of nonadrenergic serotonergic and GABAergic neurones in Alzheimer’s disease. J. Neurol. Sci., 84, 101–116.

    Article  PubMed  CAS  Google Scholar 

  • Rocca, W.A., Hoffmann, A., Brayne, C. et al. (1991) Frequency and distribution of Alzheimer’s disease in Europe: a collaborative study of 1980-1990 prevalence findings. Ann. Neurol., 30, 381–390.

    Article  PubMed  CAS  Google Scholar 

  • Rossor, M.N., Emson, P.C., Iversen, L.L. et al. (1982) Neuropeptides and neurotransmitters in cerebral cortex in Alzheimer’s disease, in Alzheimer’s Disease: A Report of Progress. (Aging, Vol. 19), (eds. S. Corkin, K.L. Davis, J.H. Growdon, E. Usdin and R.J. Wurtman), Raven Press, New York, pp. 15–24.

    Google Scholar 

  • Roth, M. (1955) The natural history of mental disorder in old age. J. Mental Sci., 101, 281–301.

    CAS  Google Scholar 

  • Roth, M., Tomlinson, B.E. and Blessed, G. (1966) Correlation between scores of dementia and counts of’ senile plaques’ in cerebral grey matter of elderly subjects. Nature, 209, 109–111.

    Article  PubMed  CAS  Google Scholar 

  • Sarter, M. (1991) Taking stock of cognitive enhancers. Trends Pharmacol. Sci., 12, 456–461.

    Article  PubMed  CAS  Google Scholar 

  • Saunders, J. and Freedman, S.B. (1989) The design of full agonists for the cortical muscarinic receptor. TIPS, 10(Suppl.), 70–75.

    Google Scholar 

  • Schwartz, B.L., Hashtroudi, S., Herting, R.L. et al. (1991) Glycine prodrug facilitates memory retrieval in humans. Neurology, 41, 1341–1343.

    Article  PubMed  CAS  Google Scholar 

  • Sheldon, P.W. and Aghajanian, G.K. (1990) Serotonin (5-HT) induces IPSPs in pyramidal layer cells of the rat piriform cortex: Evidence for the involvement of a 5-HT2 activated interneurone. Brain Res., 506, 62–69.

    Article  PubMed  CAS  Google Scholar 

  • Siesjö, B.K. and Bengtsson, F. (1989) Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischaemia, hypoglycaemia, and spreading depression; a unifying hypothesis. J. Cerebr. Blood Flow Metab., 9, 127–140.

    Article  Google Scholar 

  • Sijbesma, H., Schipper, J., De Kloet, E.R. et al. (1991) Postsynaptic 5-HT1 receptors and offensive aggression in rat: a combined behavioural and autoradiographic study with eltoprazine. Pharmacol. Biochem. Behav., 38, 447–458.

    Article  PubMed  CAS  Google Scholar 

  • Sims, N.R. (1990) Altered glucose metabolism in Alzheimer’s disease. Ann. Neurol., 27, 691–692.

    Article  PubMed  CAS  Google Scholar 

  • Sims, N.R., Bowen, D.M., Allen, S.J. et al. (1983a) Presynaptic cholinergic dysfunction in patients with dementia. J. Neurochem., 40, 503–509.

    Article  PubMed  CAS  Google Scholar 

  • Sims, N.R., Bowen, D.M., Neary, D. and Davison, A.N. (1983b) Metabolic processes in Alzheimer’s disease: adenine nucleotide content and production of 14CO2 from [U-14C] glucose in vitro in human neocortex. J. Neurochem., 41, 1329–1334.

    Article  PubMed  CAS  Google Scholar 

  • Sims, N.R., Finegan, J.M., Blass, J.P. et al. (1987) Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res., 436, 30–33.

    Article  PubMed  CAS  Google Scholar 

  • Small, H.D., Moir, R.D., Fuller, S.J. et al. (1991) A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer’s disease. Biochemistry, 30, 10795–10799.

    Article  PubMed  CAS  Google Scholar 

  • Smith, C.C.T., Bowen, D.M. and Davison, A.N. (1983) The evoked release of endogenous amino acids from tissue prisms of human neocortex. Brain Res., 269, 103–109.

    Article  PubMed  CAS  Google Scholar 

  • Smith, C.C.T., Bowen, D.M., Sims, N.R. et al. (1983b) Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer’s disease. Brain Res., 264, 138–141.

    Article  PubMed  CAS  Google Scholar 

  • Spillane, J.A., White, P., Goodhardt, M.J. et al. (1977) Selective vulnerability of neurones in organic dementia. Nature, 266, 558–559.

    Article  PubMed  CAS  Google Scholar 

  • Steele, J.E., Cross, A.J. and Bowen, D.M. (1991) Ligand binding to the N-methyl-D-aspartate receptor in brains from controls and Alzheimer’s disease patients. Br. J. Pharmacol., 104, 242.

    Google Scholar 

  • Summers, W.K., Majovski, L.V., Marsh, G.M. et al. (1986) Oral tetrahydroaminoacridine in long term treatment of senile dementia Alzheimer type. N. Engl. J. Med., 315, 1241–1245.

    Article  PubMed  CAS  Google Scholar 

  • Tamminga, C.A., Foster, N.L., Fedio, P. et al. (1987) Alzheimer’s disease: Low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism. Neurology, 37, 161–165.

    Article  PubMed  CAS  Google Scholar 

  • Tariot, P.N., Sunderland, T., Cohen, R.M. et al. (1988) Multiple-dose arecoline infusions in Alzheimer’s disease. Arch. Gen. Psychiatry, 45, 901–905.

    Article  PubMed  CAS  Google Scholar 

  • Terry, R.D., Masliah, E., Salmon, D.P. et al. (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol., 30, 572–580.

    Article  PubMed  CAS  Google Scholar 

  • Thal, L.J. (1990) THA, A putative drug in the treatment of Alzheimer’s disease? Acta Neurol. Scand., 82, 27–28.

    Article  Google Scholar 

  • Thompson, T.L., Filley, C.M., Mitchell, W.D. et al. (1990) Lack of efficacy of hydergine in patients with Alzheimer’s diseases. N. Engl. J. Med., 23, 445–448.

    Article  Google Scholar 

  • Tricklebank, M.D., Hutson, P.H. and Curzon, G.C. (1984) Analgesia induced by brief or more prolonged stress differs in its dependency on naloxone, 5-hydroxytryptamine and previous testing of analgesia. Neuropharmacology, 23, 417–421.

    Article  PubMed  CAS  Google Scholar 

  • Waeber, C., Dietl, M.M., Hoyer, D. and Palacios, J.M. (1989) 5-HT1-receptors in the vertebrate brain. Regional distribution examined by autoradiography. Naunyn-Schmiedebergs Arch. Pharmacol., 340, 486–494.

    PubMed  CAS  Google Scholar 

  • Wesnes, K., Jones, R.W. and Kirby, J. (1991) The effects of D-cycloserine, a glycine agonist, in a human model of the cognitive deficits associated with ageing and dementia. Br. J. Clin. Pharmacol., 31, 577–578.

    Google Scholar 

  • Wetzel, W., Getsova, V.M., Jork, R. and Matthies, H. (1980) Effect of serotonin on Y-maze retention and hippocampal protein synthesis in rats. Pharmacol. Biochem. Behav., 12, 319–322.

    Article  PubMed  CAS  Google Scholar 

  • White, P., Hiley, C.R., Goodhardt, M.J. et al. (1977) Neocortical cholinergic neurons in elderly people. Lancet, 1, 668–671.

    Article  PubMed  CAS  Google Scholar 

  • Whitehouse, P.J., Price, D.L., Strubble, R.G. et al. (1982) Alzheimer’s disease and senile dementia: loss of neurones in basal forebrain. Science, 215, 1237–1239.

    Article  PubMed  CAS  Google Scholar 

  • Whitehouse, P.J., Martion, A.M., Marcus, K.A. and Zweig, R.M. (1988) Reductions in acetylcholine and nicotine binding in several degenerative diseases. Arch. Neurol., 45, 722–724.

    Article  PubMed  CAS  Google Scholar 

  • Wilkins, R.H. and Brody, I.A. (1969) Alzheimer’s Disease. Arch. Neurol., 21, 109–110.

    Article  PubMed  CAS  Google Scholar 

  • Wilson, R.S. and Martin, E.M. (1988) New intrathecal drugs in Alzheimer’s disease and psychometric testing. Annal. New York Acad. Sci., 531, 180–186.

    Article  CAS  Google Scholar 

  • Yates, C.M., Butterworth, J., Tennant, M.C. and Gordon, A. (1990) Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J. Neurochem., 55, 1624–1630.

    Article  PubMed  CAS  Google Scholar 

  • Zilles, K., Zur Nieden, K., Schleicher, A. and Traber, J. (1990) A new method for quenching correction leads to revisions of data in receptor autoradiography. Histochemistry, 94, 569–578.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Paul T. Francis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David M. Bowen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Physiology, University of Manchester, UK

    Frank Owen

  2. Department of Optometry and Vision Sciences, UMIST, UK

    Ruth Itzhaki

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Francis, P.T., Bowen, D.M. (1994). Neuronal pathology in relation to molecular biology and treatment of Alzheimer’s disease. In: Owen, F., Itzhaki, R. (eds) Molecular and Cell Biology of Neuropsychiatric Diseases. Molecular and Cell Biology of Human Diseases Series. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0709-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-0709-9_2

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4305-2

  • Online ISBN: 978-94-011-0709-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation